Stocktoria
PROCEPT BioRobotics Corp PRCT
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2021-09-15
PROCEPT BioRobotics Corp statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross margin | 63.7% | 61.1% | 52.2% | 49.4% | 46.0% |
| Operating margin | -33.7% | -43.0% | -80.2% | -107.6% | -157.1% |
| Net margin | -31.0% | -40.7% | -77.8% | -116.2% | -173.6% |
| FCF margin | -18.9% | -46.2% | -97.8% | -110.7% | -168.0% |
| Return on assets | -18.8% | -17.1% | -26.2% | -28.2% | -17.8% |
| Return on equity | -26.1% | -22.7% | -37.7% | -44.2% | -22.4% |
| Debt / equity | 0.14× | 0.13× | 0.18× | 0.26× | 0.19× |
| Current ratio | 6.85 | 9.07 | 7.63 | 7.73 | 20.08 |
| Revenue growth | 37.2% | 64.8% | 81.6% | 117.6% | 346.7% |
Source: SEC EDGAR filings · CIK 0001588978 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.